Key result
Sodium nitroprusside provides safe, powerful vasodilation for acute heart failure, hypertensive crises, and aortic dissection.
Why the study?
Despite its utility in critical care, concerns remain regarding the manageability and potential toxicity of sodium nitroprusside.
Sodium nitroprusside remains a valuable and safe vasodilator for critical care applications such as acute heart failure and hypertensive emergencies when appropriately managed.
Supports nitroprusside in monitored acute HF and crises; leaves open need for contemporary RCTs.
Sodium nitroprusside (SNP) is a powerful vasodilator approved for treating acute hypertensive crises, acute heart failure, aortic dissection, and both controlled perioperative hypotension and perioperative hypertension. Its unique ability to cause both venous and arterial dilation makes it an invaluable option in critical care settings. Despite concerns regarding its manageability due to potential toxicity, it is a safe choice if properly used, as highlighted by its short half-life and minimal side effects. This review aims to summarize its pharmacological properties, toxicology, and various clinical applications, particularly focusing on acute heart failure and hypertensive emergencies.
No takes yet. Share an insight, caveat, or question.
D’Elia et al. (2024) conducted a review in Acute heart failure, hypertensive crises, aortic dissection. Sodium nitroprusside was evaluated. Sodium nitroprusside is a powerful and safe vasodilator for treating acute heart failure, hypertensive crises, and aortic dissection when properly used.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: